Skip to main content
. 2011 Nov 1;53(9):952–960. doi: 10.1093/cid/cir606

Figure 2.

Figure 2.

Baseline body mass index (BMI) and the probability of attaining a 12-month CD4+ lymphocyte count >200 or >350 cells/μL. Regression lines are adjusted for age, race, protease inhibitor usage, year of antiretroviral therapy initiation, and baseline CD4+ lymphocyte count and plasma HIV-1 RNA level (log10 transformed); dashed lines represent 95% confidence intervals.